• GROWING: AMAG is focused on driving organic growth of its products in their indicated patient populations.

  • BUILDING: AMAG intends to expand its portfolio with additional specialty products that leverage the company’s strong foundation.

  • TOGETHER: We will develop and build AMAG’s organizational capabilities to support our planned growth and expansion.

AMAG is a fast-growing, specialty pharmaceutical company, supported by a talented and passionate workforce. Our primary goal is to bring to market medical therapies and other innovations that provide clear benefits and improve people’s lives.

AMAG Pharmaceuticals acquired Lumara HealthTM, a specialty pharmaceutical company dedicated to advancing women’s health, in November 2014. For more information, please visit www.lumarahealth.com.

AMAG currently markets an intravenous iron for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD) in the United States.

LEARN MORE

AMAG currently markets an oral rinse for the management of oral mucositis in the United States.

LEARN MORE

The Growth You Can’t See helps to raise awareness of preterm birth, the health and developmental risks associated with preterm birth and the importance of a full-term pregnancy.

READ MORE

AMAG recently launched Iron Matters™ to help educate patients about iron deficiency anemia (IDA).

READ MORE